Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

19 mars 2026 09h00 HE | Source: Levi & Korsinsky, LLP

IMMP Investor Alert: Immutep Ltd. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Management Allegedly Misrepresented Trial Progress: Levi & Korsinsky

NEW YORK, March 19, 2026 (GLOBE NEWSWIRE) -- Shareholders of Immutep Ltd. (NASDAQ: IMMP) who lost money are urged to act now. On January 30, 2026, Immutep filed a 6-K stating that completion of the...
19 mars 2026 09h00 HE | Source: Levi & Korsinsky, LLP

PODD Investor Alert: Insulet Corp. Potential Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Executives Allegedly Misled on Safety: Levi & Korsinsky

NEW YORK, March 19, 2026 (GLOBE NEWSWIRE) -- On February 18, 2026, Insulet Corp. (NASDAQ: PODD) CEO Ashley McEvoy told investors on the Q4 2025 earnings call that "our results in the fourth quarter...
19 mars 2026 09h00 HE | Source: Levi & Korsinsky, LLP

PRCT: Guided $325.5M, Hid Pricing Headwind -- Levi & Korsinsky, LLP Investigates

PRCT: Guided $325.5M, Hid Pricing Headwind -- Levi & Korsinsky, LLP Investigates Procept BioRobotics set aggressive revenue targets while a internal pricing change was already undercutting...
19 mars 2026 09h00 HE | Source: Levi & Korsinsky, LLP

IRON Drops Up to 39% After FDA CRL for Bitopertin -- LEVI & KORSINSKY, LLP Investigates

NEW YORK, March 19, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP is investigating Disc Medicine, Inc. (NASDAQ: IRON) regarding whether the company adequately communicated risks regarding its...
19 mars 2026 09h00 HE | Source: Levi & Korsinsky, LLP

Ziff Davis (ZD) Guided for Growth, Delivered a Decline -- Levi & Korsinsky, LLP Investigates

NEW YORK, March 19, 2026 (GLOBE NEWSWIRE) -- Ziff Davis, Inc. (NASDAQ: ZD) investors lost more than 10% of their holdings after the Company reported Q4 2025 results that contradicted months of...
19 mars 2026 09h00 HE | Source: Levi & Korsinsky, LLP

Levi & Korsinsky, LLP: Grail (GRAL) Guided to 2030 Cash Runway While Key Trial Risk Went Unaddressed

NEW YORK, March 19, 2026 (GLOBE NEWSWIRE) -- Grail, Inc. (NASDAQ: GRAL) lost approximately 50% of its market value after disclosing that the NHS Galleri randomized trial failed to meet its primary...
19 mars 2026 09h00 HE | Source: Levi & Korsinsky, LLP

GOSS: Management Optimistic About Topline Results -- LEVI & KORSINSKY, LLP Investigates After Trial Fails

NEW YORK, March 19, 2026 (GLOBE NEWSWIRE) -- Gossamer Bio, Inc. (NASDAQ: GOSS) shareholders suffered significant losses when the Company disclosed that its Phase 3 PROSERA study of seralutinib...
19 mars 2026 09h00 HE | Source: Levi & Korsinsky, LLP

GIII Investor Alert: G-III Apparel Group Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Executives Allegedly Misled on Earnings: Levi & Korsinsky

NEW YORK, March 19, 2026 (GLOBE NEWSWIRE) -- Investors in G-III Apparel Group, Ltd. (NASDAQ: GIII) lost more than 11% of their share value on March 12, 2026, after the company reported full-year...
19 mars 2026 09h00 HE | Source: Levi & Korsinsky, LLP

TBPH Guided for $75M in Milestones While Trial Risk Went Unquantified -- LEVI & KORSINSKY, LLP

NEW YORK, March 19, 2026 (GLOBE NEWSWIRE) -- Theravance Biopharma (NASDAQ: TBPH) shareholders lost approximately 26% when shares collapsed on March 3, 2026. In the quarters leading up to that drop,...
19 mars 2026 09h00 HE | Source: Levi & Korsinsky, LLP

CAR Shareholders Lost Money? Levi & Korsinsky, LLP Probes Reported vs. Actual Figures

NEW YORK, March 19, 2026 (GLOBE NEWSWIRE) -- Avis Budget Group (NASDAQ: CAR) reported adjusted EBITDA growth of 11% for Q4 2025. Under GAAP, the Company posted a net loss of $856 million....

Page suivante